Reps. David McKinley (R-WV) and Mike Thompson (D-CA) last night introduced H.R. 4392, a bill that would prevent a dramatic reduction in Medicare Part B payments for certain hospitals that participate in the 340B Drug Pricing Program. The Centers for Medicare & Medicaid Services recently released a final rule that reduces by nearly 30%, or $1.6 billion, Medicare payments to certain public and non-profit hospitals for outpatient drugs purchased under the 340B program. “The AHA thanks Representatives McKinley and Thompson for leading this bipartisan effort to protect patient care by preventing CMS from reducing Medicare Part B payments for some 340B hospitals,” said AHA Executive Vice President Tom Nickels. “For 25 years, the 340B program has been critical in helping hospitals expand access to lifesaving prescription drugs and comprehensive health care to low-income patients and other vulnerable populations in communities across the country.” The AHA, joined by the Association of American Medical Colleges and America's Essential Hospitals, Nov. 13 filed a federal lawsuit to prevent CMS from implementing these cuts.

Related News Articles

Headline
“As pharmaceutical companies throw stone after stone at the 340B program, they should beware of their own glass house. Their complaints ring hollow when it is…
Headline
The AHA Sept. 17 urged the Department of Health and Human Services’ Office of Inspector General to further scrutinize policies and practices by certain…
Headline
The Health Resources and Services Administration Sept. 17 told Johnson & Johnson that the company’s publicly announced plans to implement a 340B rebate…
Headline
The Centers for Medicare & Medicaid services Sept. 10 announced the opening of a 60-day public comment period regarding its proposed plan for new data…
Headline
Hospitals and health systems are seeing significant increases in administrative costs, including due to burdensome practices by commercial insurers that often…
Headline
The AHA Sept. 9 released a report highlighting how hospitals’ arrangements with community and specialty pharmacies improve access to care for underserved…